Skip to content
Pill with imprint A25, orange, round, 7 mm (Eltrombopag 25 mg)

A25 pill

Pill with imprint A25 is orange, round, 7 mm and has been identified as Eltrombopag 25 mg. It is used for aplastic anemia and idiopathic thrombocytopenic purpura. It is supplied by Amneal Pharmaceuticals Ny LLC.

Eltrombopag 25 mg

Imprint
A25
Strength
25 mg
Used for
Aplastic anemia and idiopathic thrombocytopenic purpura
Color
Orange
Shape
Round
Size
7 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Amneal Pharmaceuticals Ny LLC
Drug class
Thrombopoietin receptor agonist
NDC
69238-1416, 69238-1416-3, 60219-1416, 60219-1416-3, 42291-933, 42291-933-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked . Photo: Amneal Pharmaceuticals.

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Eltrombopag pills and guides

What is Eltrombopag used for?

Eltrombopag is used for aplastic anemia and idiopathic thrombocytopenic purpura.

Medicine type
Thrombopoietin receptor agonist
Official uses from the US prescribing label

Treatment of Thrombocytopenia in Patients with Hepatitis C Infection

Eltrombopag tablets are indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

Treatment of Severe Aplastic Anemia

  • Eltrombopag tablets are indicated in combination with standard immunosuppressive therapy (IST) for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
  • Eltrombopag tablets are indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

Limitations of Use

  • Eltrombopag tablets are not indicated for the treatment of patients with myelodysplastic syndromes (MDS).
  • Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for treatment of chronic hepatitis C infection.

From the FDA-approved label on DailyMed (published Sep 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows A25.
  • It is orange, round, 7 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Eltrombopag Olamine.

Ingredients

Active: Eltrombopag Olamine

Inactive: D&c Red No. 27, D&c Yellow No. 10, Fd&c Blue No. 1, Hypromellose, Unspecified, Magnesium Stearate, Mannitol, Microcrystalline Cellulose, Polyethylene Glycol 6000, Povidone K30, Sodium Starch Glycolate Type A Potato, Titanium Dioxide

Also distributed by

Avkare

Other pills with imprint A 25

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Eltrombopag pills